Prostate cancer Board decisions

The Board denied service connection for dental trauma, prostate cancer, and facial scars as there is no evidence of inservice exposure to ionizing radiation, and the conditions are not related to the Veteran's military service.

The Board denied service connection for diabetes mellitus, prostate cancer, arteriosclerotic heart disease, and peripheral vascular disease as the evidence did not establish a relevant injury in service or that any of these conditions were manifested within one year after service.

The Board denied service connection for prostate cancer, finding no evidence of in-service exposure to Agent Orange and no medical evidence linking the condition to military service.

The Board denied service connection for prostate cancer and continued the 10 percent rating for a right shoulder disability, increasing it to 20 percent effective May 4, 2007.

The Board denied service connection for prostate cancer, cataracts, scabies, and a condition requiring an angioplasty. The claims to reopen for malaria, hepatitis, bronchitis, and POW status were also denied.

The Board denied service connection for the cause of the Veteran's death due to prostate cancer, as there was no evidence linking the disease to his military service.

The Board denied service connection for prostate cancer, finding no evidence that the Veteran's condition was related to his military service or Agent Orange exposure.

The Board denied the Veteran's claim for service connection for prostate cancer, as there was no evidence of a relationship between the condition and his military service.

The Board denied the Veteran's claim for service connection for prostate cancer, as there was no evidence of in-service exposure to herbicides or a causal relationship between his prostate cancer and military service.

The appeal was remanded for additional development, specifically to obtain a revised report from the Under Secretary of Health considering BEIR VII.

The Board determined that the severance of service connection for non-Hodgkin's lymphoma, residuals of prostate cancer, status post phlebitis with chronic venous insufficiency of the left leg, and fibrosis of the skin of the left neck was improper. The claims for service connection for colon cancer and skin cancer were denied.

The Board concluded that the reduction of the veteran's rating for residuals of prostate cancer was proper, as there had been clear improvement in his condition with no recurrence or metastasis.

The Board denied the Veteran's claim for service connection for prostate cancer, as there was no evidence of a nexus between the condition and his military service.

The Board denied service connection for depression and status post radical retropubic prostatectomy due to prostate cancer, as there was no evidence linking these conditions to the Veteran's military service or Agent Orange exposure.

The Board remands the claims for service connection for lung cancer, prostate cancer, diabetes mellitus, and gastroesophageal reflux disease to the RO/AMC for further development.

The Board finds that the preponderance of the competent and probative evidence is against the veteran's claim for service connection for prostate cancer, claimed as secondary to renal cell carcinoma and/or service-connected status postoperative right inguinal hernia.

The Board denied service connection for a left ankle disorder with left foot degenerative joint disease and prostate cancer, finding no evidence of a relationship to the veteran's active military service.

The veteran's case must be remanded to the RO for scheduling a videoconference Board hearing due to his request and the need to comply with due process.

The Veteran's diabetes mellitus was rated at 40 percent, and his post-operative residuals of prostate cancer were not found to warrant a rating higher than the currently assigned levels.

The veteran's service-connected residuals of prostate cancer were rated as noncompensably disabling from January 4, 2007, and then increased to 40 percent disabling from August 24, 2007, but not beyond.